145 related articles for article (PubMed ID: 33116584)
61. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
62. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
63. CircCDR1as Suppresses Bone Microvascular Endothelial Cell Activity and Angiogenesis Through Targeting miR-135b/ FIH-1 Axis.
Mao Z; Liu G; Xiao GY; Zhao C; Zou YC
Orthop Surg; 2021 Apr; 13(2):573-582. PubMed ID: 33619902
[TBL] [Abstract][Full Text] [Related]
64. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
Magalhães L; Quintana LG; Lopes DCF; Vidal AF; Pereira AL; D'Araujo Pinto LC; de Jesus Viana Pinheiro J; Khayat AS; Goulart LR; Burbano R; de Assumpção PP; Ribeiro-Dos-Santos Â
BMC Cancer; 2018 Oct; 18(1):1055. PubMed ID: 30376837
[TBL] [Abstract][Full Text] [Related]
65. CircLARP4 Suppresses Cell Proliferation, Invasion and Glycolysis and Promotes Apoptosis in Non-Small Cell Lung Cancer by Targeting miR-135b.
Lu H; Guo Q; Mao G; Zhu J; Li F
Onco Targets Ther; 2020; 13():3717-3728. PubMed ID: 32440141
[TBL] [Abstract][Full Text] [Related]
66. The Clinical Significance of miR-135b-5p and Its Role in the Proliferation and Apoptosis of Hippocampus Neurons in Children with Temporal Lobe Epilepsy.
Li R; Hu J; Cao S
Dev Neurosci; 2020; 42(5-6):187-194. PubMed ID: 33596573
[TBL] [Abstract][Full Text] [Related]
67. MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1.
Zhang XH; Xin ZM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1309-1315. PubMed ID: 32096167
[TBL] [Abstract][Full Text] [Related]
68. MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.
He R; Yang L; Lin X; Chen X; Lin X; Wei F; Liang X; Luo Y; Wu Y; Gan T; Dang Y; Chen G
Int J Clin Exp Pathol; 2015; 8(12):15632-41. PubMed ID: 26884832
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
70. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
Zhou C; Chen Z; Peng C; Chen C; Li H
Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716
[No Abstract] [Full Text] [Related]
71. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
Wang JT; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
[TBL] [Abstract][Full Text] [Related]
72. MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4.
Liu D; Jin Y; Wu J; Zhu H; Ye D
Cell Death Discov; 2022 Jan; 8(1):23. PubMed ID: 35027543
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.
Wang J; Chen T; Wang L; Yao B; Sun L; Chen S; Liu Q
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):485-494. PubMed ID: 31793036
[TBL] [Abstract][Full Text] [Related]
75. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
76. DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis.
Min J; Jin D; Zhang F; Kang Y; Qi Y; Du P
Cancer Cell Int; 2021 Jan; 21(1):16. PubMed ID: 33407499
[TBL] [Abstract][Full Text] [Related]
77. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374
[TBL] [Abstract][Full Text] [Related]
78. MiR-135b promotes HCC tumorigenesis through a positive-feedback loop.
Xin Y; Yang X; Xiao J; Zhao W; Li Y; Lu L; He X; Zhan M
Biochem Biophys Res Commun; 2020 Sep; 530(1):259-265. PubMed ID: 32828296
[TBL] [Abstract][Full Text] [Related]
79. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
80. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
